Back
Pliant Therapeutics Vs. BridgeBio Pharma Industry Stock Comparison
Buy
60
PLRX
Pliant Therapeutics
Last Price:
14.64
Seasonality Move:
0.26%
Buy
51
BBIO
BridgeBio Pharma
Last Price:
24.21
Seasonality Move:
24.17%
Buy
60
Pliant Therapeutics (PLRX)
is a Buy
Is Pliant Therapeutics a Buy, Sell or Hold?
- The current Pliant Therapeutics [PLRX] share price is $14.72. The Score for PLRX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- PLRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy, Sell or Hold?
- The current BridgeBio Pharma [BBIO] share price is $24.50. The Score for BBIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $14.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight selling pressure.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $24.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing slight buying pressure.
PLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 61.83 | Buy |
| Chaikin Money Flow: | -6991 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.11 - 14.37) | Buy |
| Bollinger Bands (100): | (11.21 - 13.63) | Buy |
BBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 44.58 | Sell |
| Chaikin Money Flow: | 258675 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.28 - 25.62) | Sell |
| Bollinger Bands (100): | (24.36 - 27.74) | Sell |
PLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.51 | Buy |
| 20-day SMA: | 13.11 | Buy |
| 50-day SMA: | 12.77 | Buy |
| 200-day SMA: | 13.68 | Buy |
| 8-day EMA: | 14.33 | Buy |
| 20-day EMA: | 13.57 | Buy |
| 50-day EMA: | 12.96 | Buy |
| 200-day EMA: | 13.75 | Buy |
BBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.69 | Sell |
| 20-day SMA: | 24.98 | Sell |
| 50-day SMA: | 26 | Sell |
| 200-day SMA: | 28.33 | Sell |
| 8-day EMA: | 24.61 | Sell |
| 20-day EMA: | 25.02 | Sell |
| 50-day EMA: | 25.59 | Sell |
| 200-day EMA: | 26.89 | Sell |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.32 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.24 per share, and a decrease next year of $1.05 per share.
Pliant Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BridgeBio Pharma Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||